La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Biotest Croissance future
Future contrôle des critères 0/6
Biotest's revenue and earnings are forecast to decline at 4.1% and 67.2% per annum respectively while EPS is expected to decline by 84.1% per annum.
Informations clés
-67.2%
Taux de croissance des bénéfices
-84.1%
Taux de croissance du BPA
Biotechs croissance des bénéfices | 34.0% |
Taux de croissance des recettes | -4.1% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 10 May 2024 |
Mises à jour récentes de la croissance future
Recent updates
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2025 | 712 | 59 | N/A | N/A | 1 |
12/31/2024 | 636 | -4 | N/A | N/A | 1 |
6/30/2024 | 781 | 164 | 86 | 119 | N/A |
3/31/2024 | 783 | 177 | -10 | 23 | N/A |
12/31/2023 | 685 | 127 | -36 | -3 | N/A |
9/30/2023 | 683 | 119 | -122 | -93 | N/A |
6/30/2023 | 538 | -10 | -146 | -117 | N/A |
3/31/2023 | 517 | -47 | -127 | -98 | N/A |
12/31/2022 | 516 | -32 | -70 | -40 | N/A |
9/30/2022 | 505 | -69 | -4 | 14 | N/A |
6/30/2022 | 511 | -65 | 30 | 49 | N/A |
3/31/2022 | 512 | -54 | 51 | 69 | N/A |
12/31/2021 | 516 | -63 | 16 | 34 | N/A |
9/30/2021 | 514 | -28 | -3 | 24 | N/A |
6/30/2021 | 507 | -33 | -32 | -5 | N/A |
3/31/2021 | 507 | -35 | -49 | -22 | N/A |
12/31/2020 | 484 | -31 | -44 | -17 | N/A |
9/30/2020 | 466 | -34 | -74 | -40 | N/A |
6/30/2020 | 459 | -24 | -83 | -49 | N/A |
3/31/2020 | 439 | -15 | -70 | -36 | N/A |
12/31/2019 | 419 | -5 | -68 | -34 | N/A |
9/30/2019 | 406 | -9 | -74 | -19 | N/A |
6/30/2019 | 395 | -3 | -61 | -6 | N/A |
3/31/2019 | 390 | -6 | -81 | -26 | N/A |
12/31/2018 | 400 | -13 | -105 | -50 | N/A |
9/30/2018 | 405 | 18 | -123 | -16 | N/A |
6/30/2018 | 409 | 6 | -100 | 6 | N/A |
3/31/2018 | 400 | 1 | N/A | 15 | N/A |
12/31/2017 | 378 | -16 | N/A | 34 | N/A |
9/30/2017 | 257 | -48 | N/A | 8 | N/A |
6/30/2017 | 301 | -47 | N/A | -8 | N/A |
3/31/2017 | 340 | -29 | N/A | 35 | N/A |
12/31/2016 | 408 | 6 | N/A | 66 | N/A |
9/30/2016 | 531 | 128 | N/A | 51 | N/A |
6/30/2016 | 525 | 52 | N/A | 57 | N/A |
3/31/2016 | 526 | 36 | N/A | 44 | N/A |
12/31/2015 | 535 | 27 | N/A | 38 | N/A |
9/30/2015 | 590 | -88 | N/A | 62 | N/A |
6/30/2015 | 606 | 3 | N/A | 54 | N/A |
3/31/2015 | 602 | 16 | N/A | 15 | N/A |
12/31/2014 | 582 | 19 | N/A | -11 | N/A |
9/30/2014 | 543 | 27 | N/A | -26 | N/A |
6/30/2014 | 522 | 31 | N/A | -28 | N/A |
3/31/2014 | 504 | 30 | N/A | -1 | N/A |
12/31/2013 | 501 | 32 | N/A | -7 | N/A |
9/30/2013 | 483 | 32 | N/A | 10 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: BIO3's earnings are forecast to decline over the next 3 years (-67.2% per year).
Bénéfices vs marché: BIO3's earnings are forecast to decline over the next 3 years (-67.2% per year).
Croissance élevée des bénéfices: BIO3's earnings are forecast to decline over the next 3 years.
Chiffre d'affaires vs marché: BIO3's revenue is expected to decline over the next 3 years (-4.1% per year).
Croissance élevée des revenus: BIO3's revenue is forecast to decline over the next 3 years (-4.1% per year).
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if BIO3's Return on Equity is forecast to be high in 3 years time